摘要 |
We describe a polymorphic variant of a BIM {BCL2L11) gene which comprises, in 5' to 3' order, the nucleotide sequence set out in SEQ ID NO: 5 followed immediately by the nucleotide sequence set out in SEQ ID NO: 7. The BIM polymorphic variant may be characterised by lacking the nucleotide sequence set out in SEQ ID NO: 6. It may be used to detect BCR-ABL-independent TKI-resistance (resistance to treatment with tyrosine kinase inhibitors) for chronic myelogenous leukaemia, c-KIT/PDGFR-independent TKI-resistance for gastrointestinal stromal tumours (GIST), EGFR-independent TKI-resistance for non-small cell lung cancer (NSCLC) or JAK2-independent TKI-resistance for a myeloproliferative disorder, in an individual comprising such a polymorphism. |
申请人 |
NATIONAL UNIVERSITY OF SINGAPORE;SINGAPORE HEALTH SERVICES PTE LTD;AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH;RUAN, YIJUN;ONG, SIN, TIONG;NG, KING-PAN;CHUAH, CHARLES, THUAN, HENG;HILLMER, AXEL, MAXIMILIAN;JUAN, WEN, CHUN |
发明人 |
RUAN, YIJUN;ONG, SIN, TIONG;NG, KING-PAN;CHUAH, CHARLES, THUAN, HENG;HILLMER, AXEL, MAXIMILIAN;JUAN, WEN, CHUN |